Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study

IntroductionRecent research highlights the significance of insomnia and sleepiness, shifting from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA phenotypes.ObjectivesThis study aimed to characterize insomnia and sleepiness associated with OSA phenotypes and assess their...

Full description

Bibliographic Details
Main Authors: Agata Gabryelska, Szymon Turkiewicz, Piotr Białasiewicz, Filip Grzybowski, Dominik Strzelecki, Marcin Sochal
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1303778/full
_version_ 1797289792065503232
author Agata Gabryelska
Szymon Turkiewicz
Piotr Białasiewicz
Filip Grzybowski
Dominik Strzelecki
Marcin Sochal
author_facet Agata Gabryelska
Szymon Turkiewicz
Piotr Białasiewicz
Filip Grzybowski
Dominik Strzelecki
Marcin Sochal
author_sort Agata Gabryelska
collection DOAJ
description IntroductionRecent research highlights the significance of insomnia and sleepiness, shifting from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA phenotypes.ObjectivesThis study aimed to characterize insomnia and sleepiness associated with OSA phenotypes and assess their involvement in depression symptoms (DS) in OSA.Materials and methodsThis cross-sectional, clinical study included 181 participants who underwent polysomnography (PSG) and filled out questionnaires, including the Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Index (BDI). They were categorized into phenotypes: insomnia–sleepiness (I + S; ESS ≥ 11; ISI ≥ 15; n = 20), sleepiness (S; ESS ≥ 11; ISI < 15; n = 22), insomnia (I; ESS < 11; ISI ≥ 15), and asymptomatic (A; ESS < 11; ISI<15; n=55).ResultsA linear regression model for the BDI score (R2 = 0.357, p < 0.001) included ISI score and subjective-to-objective sleep latency ratio. The ISI score was a predictive factor for mild and moderate DS [OR = 1.23 (95% CI: 1.09–1.38), p < 0.001 and OR = 1.39 (95% CI: 1.13–1.72), p = 0.002]. The I and I + S phenotypes are characterized by higher BDI scores (p < 0.001 and p = 0.02), longer subjective sleep latency (p = 0.008 and p = 0.04), and shorter subjective total sleep time (TST; p = 0.049 and p = 0.006) compared to A. Furthermore, the I and I + S groups had shorter subjective TST than S (p = 0.03 and p = 0.047). The I and I + S had higher BDI scores than A (p < 0.001 and p = 0.02, respectively) and S (p < 0.001 and p = 0.02, respectively). The I phenotype was associated with the risk of mild and moderate DS (OR = 5.61 (95% CI: 1.91–16.53), p < 0.001 and OR = 9.55 (95% CI: 1.81–50.48), p = 0.008 respectively). Moreover, the I + S phenotype presented an even greater risk for mild DS (OR = 10.29 (95% CI: 2.95–35.85), p < 0.001).ConclusionUsing clinical features for OSA phenotyping holds promise for finding OSA individuals with increased risk for DS occurrence.
first_indexed 2024-03-07T19:10:10Z
format Article
id doaj.art-38d011b0cc0f421eaae82577c168fcb0
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-03-07T19:10:10Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-38d011b0cc0f421eaae82577c168fcb02024-03-01T04:27:26ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402024-03-011510.3389/fpsyt.2024.13037781303778Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical studyAgata Gabryelska0Szymon Turkiewicz1Piotr Białasiewicz2Filip Grzybowski3Dominik Strzelecki4Marcin Sochal5Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, PolandDepartment of Affective and Psychotic Disorders, Medical University of Lodz, Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, PolandIntroductionRecent research highlights the significance of insomnia and sleepiness, shifting from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA phenotypes.ObjectivesThis study aimed to characterize insomnia and sleepiness associated with OSA phenotypes and assess their involvement in depression symptoms (DS) in OSA.Materials and methodsThis cross-sectional, clinical study included 181 participants who underwent polysomnography (PSG) and filled out questionnaires, including the Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Index (BDI). They were categorized into phenotypes: insomnia–sleepiness (I + S; ESS ≥ 11; ISI ≥ 15; n = 20), sleepiness (S; ESS ≥ 11; ISI < 15; n = 22), insomnia (I; ESS < 11; ISI ≥ 15), and asymptomatic (A; ESS < 11; ISI<15; n=55).ResultsA linear regression model for the BDI score (R2 = 0.357, p < 0.001) included ISI score and subjective-to-objective sleep latency ratio. The ISI score was a predictive factor for mild and moderate DS [OR = 1.23 (95% CI: 1.09–1.38), p < 0.001 and OR = 1.39 (95% CI: 1.13–1.72), p = 0.002]. The I and I + S phenotypes are characterized by higher BDI scores (p < 0.001 and p = 0.02), longer subjective sleep latency (p = 0.008 and p = 0.04), and shorter subjective total sleep time (TST; p = 0.049 and p = 0.006) compared to A. Furthermore, the I and I + S groups had shorter subjective TST than S (p = 0.03 and p = 0.047). The I and I + S had higher BDI scores than A (p < 0.001 and p = 0.02, respectively) and S (p < 0.001 and p = 0.02, respectively). The I phenotype was associated with the risk of mild and moderate DS (OR = 5.61 (95% CI: 1.91–16.53), p < 0.001 and OR = 9.55 (95% CI: 1.81–50.48), p = 0.008 respectively). Moreover, the I + S phenotype presented an even greater risk for mild DS (OR = 10.29 (95% CI: 2.95–35.85), p < 0.001).ConclusionUsing clinical features for OSA phenotyping holds promise for finding OSA individuals with increased risk for DS occurrence.https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1303778/fullinsomniaphenotypingOSAdepressionexcessive daytime sleepiness
spellingShingle Agata Gabryelska
Szymon Turkiewicz
Piotr Białasiewicz
Filip Grzybowski
Dominik Strzelecki
Marcin Sochal
Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
Frontiers in Psychiatry
insomnia
phenotyping
OSA
depression
excessive daytime sleepiness
title Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
title_full Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
title_fullStr Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
title_full_unstemmed Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
title_short Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study
title_sort evaluation of daytime sleepiness and insomnia symptoms in osa patients with a characterization of symptom defined phenotypes and their involvement in depression comorbidity a cross sectional clinical study
topic insomnia
phenotyping
OSA
depression
excessive daytime sleepiness
url https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1303778/full
work_keys_str_mv AT agatagabryelska evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy
AT szymonturkiewicz evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy
AT piotrbiałasiewicz evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy
AT filipgrzybowski evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy
AT dominikstrzelecki evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy
AT marcinsochal evaluationofdaytimesleepinessandinsomniasymptomsinosapatientswithacharacterizationofsymptomdefinedphenotypesandtheirinvolvementindepressioncomorbidityacrosssectionalclinicalstudy